An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)

Clinical trial NCT00092183 · COMPLETED

Trial details

NCT number: NCT00092183
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Nausea Vomiting Breast Neoplasms

Start date: 2002-10-10
Primary completion: 2003-12-01
Enrollment: 866

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.